Cartesian Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2015 to Q3 2024.
  • Cartesian Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.7M, a 27% decline year-over-year.
  • Cartesian Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $22.1M, a 108% increase year-over-year.
  • Cartesian Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25.8M, a 130% increase from 2022.
  • Cartesian Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.2M, a 45% increase from 2021.
  • Cartesian Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.72M, a 42.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $22.1M $1.7M -$626K -27% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $22.7M $1.59M -$2.19M -57.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $24.9M $1.43M -$845K -37.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $25.8M $17.4M +$15.1M +664% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $10.7M $2.32M -$280K -10.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $10.9M $3.78M +$219K +6.15% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $10.7M $2.28M -$477K -17.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $11.2M $2.28M +$23K +1.02% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $11.2M $2.6M +$697K +36.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $10.5M $3.56M +$1.78M +99.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 $8.69M $2.75M +$973K +54.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $7.72M $2.25M +$1.02M +82.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 $6.7M $1.9M +$608K +46.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $6.1M $1.78M +$302K +20.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $5.79M $1.78M +$371K +26.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $5.42M $1.24M -$191K -13.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-02
Q3 2020 $5.61M $1.3M -$7K -0.54% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $5.62M $1.48M +$230K +18.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $5.39M $1.41M +$229K +19.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $5.16M $1.43M -$363K -20.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 $5.52M $1.3M -$182K -12.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $5.71M $1.25M -$35K -2.72% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $5.74M $1.18M +$27K +2.34% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $5.71M $1.79M +$579K +47.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $5.14M $1.49M +$171K +13% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $4.96M $1.29M +$423K +49% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $4.54M $1.15M +$460K +66.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $4.08M $1.21M +$442K +57.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $3.64M $1.31M +$681K +108% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.96M $863K +$496K +135% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $2.46M $693K +$411K +146% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $2.05M $769K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $633K +$381K +151% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $367K +$52K +16.5% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $282K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q3 2015 $252K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $315K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.